Biller Jonathan, CLO of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $4.1M. The latest trade was on 02/25.

BJ

BJ

Biller Jonathan

EVP and Chief Legal Officer

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/03

Trades

30 trades

Buys / sales

0 / 12

12-month net buying

−$4.1M

Last trade

02/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/25	02/26	945 sh	$486.35	$459,600.75	−6.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/17–02/18	02/19	3,720 sh2 trades	$484.18avg.	$1,801,160.88	−19.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/13	02/18	988 sh	$499.00	$493,012	−5.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/11	02/12	1,925 sh	$460.43	$886,327.75	−8.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/12/03	25/12/05	347 sh	$449.00	$155,803	−2.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/10/02	25/10/03	694 sh	$404.21	$280,521.74	−4.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/18	25/02/19	1,657 sh	$455.06	$754,034.42	−8.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/02/11	25/02/12	3,433 sh	$459.87	$1,578,733.71	−17.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/10/02	24/10/03	999 sh	$461.66	$461,198.34	−5.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/12	24/02/13	1,738 sh	$418.77	$727,822.26	−8.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/02	23/10/03	610 sh	$346.76	$211,523.6	−5.5%